Peptides for fat loss: what TikTok skips over

What did @grayannfitness actually say?

The creator made two main points. First, that peptides marketed for fat loss, specifically "Retta" (likely retatrutide or a similar GLP-1/GIP/glucagon receptor agonist), work through hunger suppression rather than direct fat burning. Second, that oral peptides affect the liver and kidneys while injected peptides "bypass that completely and keep them safe." They closed with a nudge to do independent research before trying anything.

To their credit, they flagged a common misconception head-on: people assume these compounds are metabolic accelerants. They are not. The satiety mechanism framing is broadly accurate for the class. The injection safety claim, though, is where things get complicated and where this video earns more scrutiny.

Does the science back this up?

The satiety claim holds up reasonably well. The injection-equals-kidney-safety claim does not, and that framing is potentially dangerous if viewers take it at face value.

On satiety: retatrutide (if that is what "Retta" refers to) is a triple agonist targeting GLP-1, GIP, and glucagon receptors. Phase 2 data published by Jastreboff et al. (2023, NEJM) showed up to 17.5% body weight reduction over 24 weeks, driven primarily by reduced appetite and energy intake, not thermogenic fat oxidation. The creator's framing, that it manages hunger rather than burning fat directly, is consistent with the mechanism of action described in that trial.

On injections bypassing organ stress: this is where the video oversimplifies to the point of being misleading. Injectable peptides still undergo systemic circulation. Renal filtration handles peptide clearance regardless of the administration route. Peptide fragments are processed hepatically. A study by Drucker (2018, Cell Metabolism) notes that GLP-1 receptor agonists, for example, have documented effects on gallbladder motility and require monitoring in patients with existing renal impairment.

What did they get wrong (or right)?

They got the satiety framing right. The injection safety claim is the problem, and it needs to be said plainly: injecting something does not make it safe for your organs. It changes the delivery route, not the pharmacokinetic reality.

Subcutaneous or intramuscular injection still results in the compound entering systemic circulation. The liver receives that blood. The kidneys filter it. "Bypass" implies a level of organ protection that pharmacology does not support. For someone with compromised renal function, this framing could lead them to assume injectable peptides are a safe option when they may not be.

• Right: peptides like retatrutide suppress appetite, they do not act as direct fat burners.
• Right: oral bioavailability of most peptides is low due to gastrointestinal degradation, which is a real pharmacokinetic issue.
• Wrong: the claim that injection "bypasses" liver and kidney involvement is not supported by how systemic circulation and peptide metabolism actually work.
• Unclear: "Retta" is not a standardized name. If this refers to retatrutide, it is still in clinical trials and not approved for general use.

What should you actually know?

No peptide currently approved or in late-stage trials operates as a standalone fat burner. The ones showing results in clinical data work through appetite and metabolic signaling, which still requires caloric deficit to produce fat loss. The route of administration changes how a compound enters the body, not whether your organs interact with it.

Injectable peptides, including GLP-1 class compounds, semaglutide analogs, and experimental triple agonists, are associated with side effects that include nausea, pancreatitis risk, and in some cases kidney function changes secondary to dehydration from gastrointestinal side effects. The FDA and TGA both require monitoring for patients on these compounds precisely because systemic exposure is real regardless of how they are injected.

If you are considering any peptide therapy, particularly for fat loss, the conversation starts with a licensed clinician reviewing your metabolic panel, kidney function, and cardiovascular history, not a TikTok video, including this fact-check.